Dr. Omoshile (Omo) Clement is the Founder and Executive Director of HopeScan Initiative. He brings more than 25 years of experience advancing product innovation and global market adoption of cancer research technologies, cancer diagnostic tools, and clinical testing solutions. His career spans the development and launch of companion cancer diagnostic (Dx) assays and controls, patient specimen collection devices, global testing standards for cancer and infectious diseases, and a wide range of biological reagents and consumables used across oncology diagnostics and cancer disease management.
Dr. Clement’s expertise was shaped through leadership roles at industry‑defining organizations such as Illumina, Asuragen, Bio‑Rad, LGC Clinical Diagnostics, HTG Molecular Diagnostics, and the global non-profit biorepository, ATCC. At ATCC, he oversaw the stewardship and strategic management of approximately 100,000 biological materials – the world’s largest collections – supporting global disease research, disease diagnostics, and public health.
He earned his B.S. (Honors) in Chemistry from the University of Ibadan in Nigeria, followed by an M.S. and Ph.D. in Chemistry from Queen’s University in Ontario, Canada. He completed his postdoctoral research fellowship at the Environmental Molecular Sciences Laboratory (EMSL) at the Pacific Northwest National Laboratory (PNNL) in Richland, Washington, USA.
Dr. Clement has authored nearly 30 peer‑reviewed scientific publications and delivered more than 30 poster presentations at regional, national, and international conferences. He has also been invited to co‑author three book chapters, including contributions to the Encyclopedia of Computational Chemistry (Wiley, 1998), Pharmacophore Perception, Development, and Use in Drug Design (IUL, 2000), and Protein Structure: Determination, Analysis, and Applications in Drug Discovery (Marcel Dekker, 2003).
HopeScan Initiative Inc. is a 501(c)(3) non-profit organization dedicated to expanding access to early cancer detection and life‑saving treatment for underserved communities across sub‑Saharan West Africa.
We partner with trusted clinical providers to bridge the gap between screening and care, so that individuals receive the guidance, navigation, support, and resources needed to access timely, effective cancer treatment.
Providing materials and supplies to diagnostic centers in West Africa is vital for early cancer detection and better patient outcomes.
Providing specialized training for healthcare workers helps reduce misdiagnosis and improves cancer care quality.
Educating the public and integrating screening into primary care makes cancer diagnosis more accessible and timely.
Providing materials and supplies to diagnostic centers in West Africa is vital for early cancer detection and better patient outcomes.
Providing specialized training for healthcare workers helps reduce misdiagnosis and improves cancer care quality.
Educating the public and integrating screening into primary care makes cancer diagnosis more accessible and timely.
Implementing a digital Patient Navigation system that tracks individuals from screening through diagnosis and treatment referral.
Patients with abnormal results are connected to partner hospitals and clinical specialists
Using telemedicine to link patients in remote locations with cancer specialists, will overcome geographical barriers to expert and timely care.
Collaboration with policy makers and NGOs will help minimize financial and logistical obstacles, ensuring timely, quality care for more patients.
Community-based support programs and education empower survivors to manage long-term effects and remain well-informed.
Access to specialized survivorship clinics ensures tailored care for both the physical and psychological needs of cancer survivors.
Implementing a digital Patient Navigation system that tracks individuals from screening through diagnosis and treatment referral.
Connecting patients with abnormal results are connected to partner hospitals and clinical specialists
Using telemedicine to link patients in remote locations with cancer specialists, will overcome geographical barriers to expert and timely care.
Collaboration with policy makers and NGOs will help minimize financial and logistical obstacles, ensuring timely, quality care for more patients.
Community-based support programs and education empower survivors to manage long-term effects and remain well-informed.
Access to specialized survivorship clinics ensures tailored care for both the physical and psychological needs of cancer survivors.
